Replimune's shares crater as FDA rejects melanoma drug - Fierce Biotech
The FDA has
Stay updated with the latest business news and market trends
The FDA has
Analysts Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this art…
Stock futures are little changed as investors watch for more earnings and trade developments; AstraZeneca (AZN) said it plans to invest $50 billion in U.S. production facilities; Opendoor Technologie…
Treasuries rose, reversing earlier losses, as Treasury Secretary Scott Bessent said he sees no reason for Jerome Powell to step down as Federal Reserve chair. Yields on Treasuries fell about 3 basi…
Complete digital access to quality analysis and expert insights, complemented with our award-winning Weekend Print edition. Everything in PrintWeekday Print EditionFT …
Hackers exploited a major security flaw in widely used Microsoft server software to launch a global attack on government agencies and businesses in the past few days, breaching U.S. federal and state…
U.S. stock futures were little changed Sunday night as investors tracked the latest developments on trade, and awaited the start of big tech earnings this week. Dow Jones Industrial Average futures …
Subscribe to get the latest business news and updates
We respect your privacy. Unsubscribe at any time.